Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In 1958, in a Letter to the…
More Articles
New Drugs and Therapeutics Update – NGENLA By Dania Al-Hamad, MD, and Christine Yu, MD NGENLA (somatrogon-ghla), a once-weekly, human growth hormone analog, was approved by the FDA in…
Historical Tidbit: Robert T. Morris (1857-1945) and Human Ovarian Transplantation Submitted by Alan D. Rogol, M.D., Ph.D. Robert Morris was an exceptional surgeon in New York City. He was among…
Patricia Chu, MD I am a fourth-year Combined Adult and Pediatric Endocrinology Fellow at Penn Medicine/Children’s Hospital of Philadelphia and am currently in the Master of Science in Clinical Epidemiology (MSCE)…
Brief Therapeutic Update from PES Drugs and Therapeutics Committee Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide) Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide) were approved by the…
New Meds and Tech from PES Drugs and Therapeutics committee Palovarotene (SohonosTM – Ipsen Pharmaceuticals Inc.) By: Ambika Ashraf, MD and Anna Ryabets-Lienhard, DO Update: 9/10/2023 On August…
Historical Tidbit: Paracelsus (1493-1541). A Man for All Seasons Submitted by Alan D. Rogol, M.D., Ph.D. Paracelsus, born Philippus Aureolus Theophrastue Bombastus von Hoenheim was a Swiss chemist and physician…
Ana Menendez, MD My name is Ana Menendez and I am a third-year pediatric endocrinology fellow at the University of Connecticut, Connecticut Children’s Medical Center. I obtained my medical degree…
